ZIVOW | ZIVO Bioscience, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5000 - 0.5000
52 Week Range	0.5000 - 0.5000
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	8,000
Average Volume	N/A
Shares Outstanding	2,419,400
Market Cap	1,209,700
Sector	Healthcare
Industry	Biotechnology
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	8
Country

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

ZIVOW's peers: DRMAW

*Chart delayed

Analyzing fundamentals for ZIVOW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see ZIVOW Fundamentals page.

Watching at ZIVOW technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on ZIVOW Technicals page.